Yahoo Web Search

Search results

1. • Analyst Report: Bristol-Myers Squibb Company

     Morningstar Research via Yahoo Finance· 15 hours ago

     Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where ...

2. • 

     Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?

     Simply Wall St. via Yahoo Finance· 1 day ago

     Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to...

3. • Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology...

     Morningstar· 1 day ago

     Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting Consistent with short-term studies, KarXT was not associated with clinically meaningful changes in movement disorder scale scores and a

4. • Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income...

     Morningstar· 2 days ago

     Bristol Myers Squibb (NYSE: BMY) today announced ASPIRE (Accessibility, Sustainability, Patient-centric, Impact, Responsibility and Equity), a 10-year strategy to advance access to our innovative ...

5. • 

     Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%

     Simply Wall St. via Yahoo Finance· 6 days ago

     Key Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price...

6. • Bristol-Myers Squibb Co. [BMY] Records 50-Day SMA of $48.20 – Knox Daily

     Knox Daily· 1 day ago

     Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Bristol-Myers Squibb Co. shares valued at $99,560 were purchased by BOERNER CHRISTOPHER ...

7. • Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity - Bristol-Myers Squibb...

     Benzinga· 3 days ago

     Loading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Bristol-Myers Squibb . Looking at options history for Bristol-Myers Squibb BMY we detected ...

8. • A Guide To The Risks Of Investing In Bristol-Myers Squibb Co.

     Knox Daily· 4 days ago

     Bristol-Myers Squibb Co.’s filing revealed that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on Dec 05 ’23. In the deal valued at $49.78 ...

9. • 

     Bristol Myers, Sanofi Liability in Hawaii Plavix Case Grows to $916 Million

     Insurance Journal· 1 day ago

     A judge in Hawaii on Tuesday ordered Bristol Myers Squibb and Sanofi to pay more than $916 million...

10. • Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with...

      Morningstar· 3 days ago

      Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign The national initiative, Live Your PosSCZible, ...